Quantcast

Latest Influenza vaccine Stories

2014-08-31 04:20:49

DALLAS, August 31, 2014 /PRNewswire/ -- LifeScienceIndustryResearch.com adds "China Human Vaccine Industry Report, 2014-2017 [http://www.lifescienceindustryresearch.com/china-human-vaccine-industry-report-2014-2017.html ] " that says vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China's human vaccine lot release volume grew by 4.9% from a year earlier, and the market size expanded 2.8% year on...

2014-08-28 23:08:03

Transparency Market Research published a new report "U.S. Vaccine Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018" to its report store. Albany, New York (PRWEB) August 28, 2014 Vaccine market - the once low-profit ventured industry is currently perceived with great interest among other healthcare industry sectors and sub-circles in the U.S. This is due to the high demand in vaccine with respect to evolving and spreading infectious diseases. This...

2014-08-28 23:03:49

Every August is deemed “National Immunization Awareness Month” or “NIAM” and is recognized by the U.S. Department of Health and Human Resources. Two “NJ Top Docs” Pediatricians, Dr. Stuart Slavin of Touchpoint Pediatrics and Dr. Mondana Yazdi of Wyckoff Pediatrics were invited to speak on the topic. Scotch Plains, NJ (PRWEB) August 28, 2014 Smallpox was the first disease in which a successful vaccine was produced for its treatment. Created by British physician Edward Jenner...

2014-08-28 12:29:44

Unprecedented international consortium -- including the University of Maryland School of Medicine and NIH -- now assembled to accelerate collaborative multi-site trials of candidate Ebola vaccine BALTIMORE and LONDON, Aug. 28, 2014 /PRNewswire/ -- A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400...

2014-08-28 12:29:21

Vaccinations for flu, pneumonia and more available every day at CVS/pharmacy and MinuteClinic WOONSOCKET, R.I., Aug. 28, 2014 /PRNewswire/ -- In recognition of the increased risks that seniors have of developing health complications from the flu, pneumonia, shingles and other illnesses, CVS/pharmacy(®) and MinuteClinic(®) have declared September to be Senior Vaccination Month. Because people's immune systems weaken as they age, it is important that adults ages 65 years and older...

2014-08-27 23:13:03

Honoring National Immunization Awareness Month, New York Times and USA Today Best Selling author, Sanjay Jain, M.D. MBA explains how to identify and stay on top of immunizations for every age group. Washington, DC (PRWEB) August 27, 2014 The purpose behind vaccinations is to help "teach" the body how to effectively build up immunity for the future and fight off infectious agents that may cause disease. The immune system contains a diverse network of tissues, organs, and highly...

2014-08-27 08:26:54

BEIJING, Aug. 27, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2014 Annual General Meeting of Shareholders held on Wednesday, August 27, 2014 in Beijing, PRC. The required quorum, a majority of the common shares outstanding, was voted by proxy. The Company's shareholders approved the following proposals: -- The re-election of Weidong Yin, Yuk Lam Lo, Simon Anderson,...

2014-08-26 16:28:19

New Analysis Provides Basis for a Synthetic Mers CoV Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Mers CoV virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 2012. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Mers CoV Blocker-Vaccine(TM) candidate,...

2014-08-26 16:28:01

New Analysis Provides Basis for a Synthetic Influenza H1N1 Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Influenza H1N1 virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 1918. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Influenza H1N1...

2014-08-26 12:28:34

New Analysis Provides Basis for a Synthetic Chikungunya Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Chikungunya virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 1953. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Chikungunya Blocker-Vaccine(TM)...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related